169 related articles for article (PubMed ID: 22453734)
1. Elevated serum levels of B-cell activating factor in pediatric renal transplant patients.
Lehnhardt A; Dunst F; van Husen M; Loos S; Oh J; Eiermann T; Koch M; Kemper MJ
Pediatr Nephrol; 2012 Aug; 27(8):1389-95. PubMed ID: 22453734
[TBL] [Abstract][Full Text] [Related]
2. B Cell Activating Factor (BAFF) in Long-term Kidney Transplant Recipients Is Not a Prognostic Marker for Allograft Dysfunction or Survival.
Kościelska-Kasprzak K; Bartoszek D; Myszka M; Kamińska D; Boratyńska M; Krajewska M; Klinger M
Transplant Proc; 2018; 50(6):1750-1754. PubMed ID: 30056894
[TBL] [Abstract][Full Text] [Related]
3. B-Cell-Activating Factor Levels Are Associated With Antibody-Mediated Histological Damage in Kidney Transplantation.
Sango C; Merino D; San Segundo D; Rodrigo E; Lopez-Hoyos M; Benito A; Ángeles Ramos M; Gómez-Román J; Arias M
Transplant Proc; 2016 Nov; 48(9):2910-2912. PubMed ID: 27932105
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant serum BAFF levels are associated with pretransplant HLA immunization and renal allograft survival.
Friebus-Kardash J; Wilde B; Keles D; Heinold A; Kribben A; Witzke O; Heinemann FM; Eisenberger U
Transpl Immunol; 2018 Apr; 47():10-17. PubMed ID: 29277566
[TBL] [Abstract][Full Text] [Related]
5. The abnormal high expression of B cell activating factor belonging to TNF superfamily (BAFF) and its potential role in kidney transplant recipients.
Xu H; He X; Liu Q; Chen Y; Zhu Y; Shi D; Zhang X
Cell Mol Immunol; 2008 Dec; 5(6):465-70. PubMed ID: 19118513
[TBL] [Abstract][Full Text] [Related]
6. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
7. Abnormal high expression of B-cell activating factor belonging to the TNF superfamily (BAFF) associated with long-term outcome in kidney transplant recipients.
Xu H; He X; Liu Q; Shi D; Chen Y; Zhu Y; Zhang X
Transplant Proc; 2009 Jun; 41(5):1552-6. PubMed ID: 19545677
[TBL] [Abstract][Full Text] [Related]
8. BAFF is increased in renal transplant patients following treatment with alemtuzumab.
Bloom D; Chang Z; Pauly K; Kwun J; Fechner J; Hayes C; Samaniego M; Knechtle S
Am J Transplant; 2009 Aug; 9(8):1835-45. PubMed ID: 19522878
[TBL] [Abstract][Full Text] [Related]
9. Elevated pretransplantation soluble BAFF is associated with an increased risk of acute antibody-mediated rejection.
Banham G; Prezzi D; Harford S; Taylor CJ; Hamer R; Higgins R; Bradley JA; Clatworthy MR
Transplantation; 2013 Aug; 96(4):413-20. PubMed ID: 23842189
[TBL] [Abstract][Full Text] [Related]
10. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.
Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R
Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881
[TBL] [Abstract][Full Text] [Related]
11. Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection.
Afzali S; Salehi S; Shahi A; Esmaeili M; Farashi Bonab S; Peykari A; Bagherpour F; Ansaripour B; Soleimanian T; Pour-Reza-Gholi F; Amirzargar A
J Immunol Res; 2021; 2021():6654992. PubMed ID: 33748289
[TBL] [Abstract][Full Text] [Related]
12. Peripheral B-cell phenotype and BAFF levels are associated with HLA immunization in patients awaiting kidney transplantation.
Snanoudj R; Candon S; Roelen DL; Jais JP; Claas FH; Legendre C; Chatenoud L
Transplantation; 2014 May; 97(9):917-24. PubMed ID: 24827764
[TBL] [Abstract][Full Text] [Related]
13. B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata.
Elela MA; Gawdat HI; Hegazy RA; Fawzy MM; Abdel Hay RM; Saadi D; Shaker O
Arch Dermatol Res; 2016 Mar; 308(2):115-21. PubMed ID: 26796544
[TBL] [Abstract][Full Text] [Related]
14. B-Cell Activating Factor Predicts Acute Rejection Risk in Kidney Transplant Recipients: A 6-Month Follow-Up Study.
Wang XZ; Wan Z; Xue WJ; Zheng J; Li Y; Ding CG
Front Immunol; 2019; 10():1046. PubMed ID: 31156628
[TBL] [Abstract][Full Text] [Related]
15. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction.
Lehnhardt AM; Strecker M; Eiermann T; Marget M; Thaiss F; Nashan B; Koch M
Clin Transplant; 2015 Apr; 29(4):359-64. PubMed ID: 25627801
[TBL] [Abstract][Full Text] [Related]
16. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
17. B Cell-Activating Factor Is Associated with Testosterone and Smoking Status in Non-Ambulatory Men with Chronic Spinal Cord Injury.
Battaglino RA; Nguyen N; Summers M; Morse LR
J Neurotrauma; 2019 Dec; 36(24):3332-3337. PubMed ID: 31020912
[TBL] [Abstract][Full Text] [Related]
18. Serum BAFF and APRIL levels in patients with PBC.
Migita K; Ilyassova B; Kovzel EF; Nersesov A; Abiru S; Maeda Y; Komori A; Ito M; Yano K; Yatsuhashi H; Shimoda S; Ishibashi H; Nakamura M
Clin Immunol; 2010 Feb; 134(2):217-25. PubMed ID: 19840904
[TBL] [Abstract][Full Text] [Related]
19. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
[TBL] [Abstract][Full Text] [Related]
20. B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients.
Pongpirul W; Chancharoenthana W; Pongpirul K; Leelahavanichkul A; Kittikowit W; Jutivorakool K; Nonthasoot B; Avihingsanon Y; Eiam-Ong S; Praditpornsilpa K; Townamchai N
Nephrology (Carlton); 2018 Feb; 23(2):169-174. PubMed ID: 27888573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
